Novel drug therapies for atrial fibrillation
Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers. Clinical evidence suggests that antiarrhythmic therapy to restore and maintain sinus rhythm (rhythm control) can reduce adverse cardiovascular outcomes in patients with...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2024
|
| In: |
Nature reviews. Cardiology
Year: 2024, Jahrgang: 21, Heft: 5, Pages: 275-276 |
| ISSN: | 1759-5010 |
| DOI: | 10.1038/s41569-024-01004-2 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41569-024-01004-2 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41569-024-01004-2 
|
| Verfasserangaben: | Felix Wiedmann, Constanze Schmidt |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1909769932 | ||
| 003 | DE-627 | ||
| 005 | 20250716212951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241128s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41569-024-01004-2 |2 doi | |
| 035 | |a (DE-627)1909769932 | ||
| 035 | |a (DE-599)KXP1909769932 | ||
| 035 | |a (OCoLC)1528014295 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wiedmann, Felix Tobias |d 1987- |e VerfasserIn |0 (DE-588)1055852441 |0 (DE-627)792733479 |0 (DE-576)411904159 |4 aut | |
| 245 | 1 | 0 | |a Novel drug therapies for atrial fibrillation |c Felix Wiedmann, Constanze Schmidt |
| 264 | 1 | |c May 2024 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 28. Februar 2024 | ||
| 500 | |a Gesehen am 28.11.2024 | ||
| 520 | |a Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers. Clinical evidence suggests that antiarrhythmic therapy to restore and maintain sinus rhythm (rhythm control) can reduce adverse cardiovascular outcomes in patients with new-onset atrial fibrillation. As a result, a paradigm shift towards rhythm control over rate control therapy is emerging, increasing the clinical need for effective and safe antiarrhythmic drugs. | ||
| 650 | 4 | |a Atrial fibrillation | |
| 650 | 4 | |a Drug therapy | |
| 700 | 1 | |a Schmidt, Constanze |e VerfasserIn |0 (DE-588)1055852174 |0 (DE-627)792733142 |0 (DE-576)411903721 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Cardiology |d Basingstoke : Nature Publishing Group, 2009 |g 21(2024), 5, Seite 275-276 |h Online-Ressource |w (DE-627)598094873 |w (DE-600)2490378-4 |w (DE-576)327495790 |x 1759-5010 |7 nnas |a Novel drug therapies for atrial fibrillation |
| 773 | 1 | 8 | |g volume:21 |g year:2024 |g number:5 |g pages:275-276 |g extent:2 |a Novel drug therapies for atrial fibrillation |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41569-024-01004-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41569-024-01004-2 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241128 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1055852174 |a Schmidt, Constanze |m 1055852174:Schmidt, Constanze |d 910000 |d 910100 |d 50000 |e 910000PS1055852174 |e 910100PS1055852174 |e 50000PS1055852174 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 |y j | ||
| 998 | |g 1055852441 |a Wiedmann, Felix Tobias |m 1055852441:Wiedmann, Felix Tobias |d 910000 |d 910100 |e 910000PW1055852441 |e 910100PW1055852441 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1909769932 |e 4624148363 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Felix Wiedmann, Constanze Schmidt"]},"language":["eng"],"person":[{"display":"Wiedmann, Felix Tobias","given":"Felix Tobias","family":"Wiedmann","role":"aut"},{"family":"Schmidt","role":"aut","display":"Schmidt, Constanze","given":"Constanze"}],"recId":"1909769932","note":["Online veröffentlicht: 28. Februar 2024","Gesehen am 28.11.2024"],"title":[{"title_sort":"Novel drug therapies for atrial fibrillation","title":"Novel drug therapies for atrial fibrillation"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"2 S."}],"id":{"eki":["1909769932"],"doi":["10.1038/s41569-024-01004-2"]},"relHost":[{"recId":"598094873","id":{"zdb":["2490378-4"],"issn":["1759-5010"],"eki":["598094873"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"partname":"Cardiology","title_sort":"Nature reviews","title":"Nature reviews"}],"origin":[{"publisher":"Nature Publishing Group","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basingstoke"}],"part":{"year":"2024","volume":"21","issue":"5","extent":"2","pages":"275-276","text":"21(2024), 5, Seite 275-276"},"language":["eng"],"note":["Gesehen am 09.03.2021"],"pubHistory":["6.2009,4 -"],"disp":"Novel drug therapies for atrial fibrillationNature reviews. Cardiology","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Nature reviews / Cardiology"},{"title":"Cardiology"}]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"May 2024"}]} | ||
| SRT | |a WIEDMANNFENOVELDRUGT2024 | ||